SPRI | Renal Cell Carcinoma: Molecular Targets And Clinical Applications, 3rd Edition (2015 EN)

Discussion in 'Medicine' started by Kanka, Mar 30, 2020.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,047
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Ronald Bukowski (Editor), Robert A. Figlin (Editor), Robert Motzer (Editor)
    Full Title: Renal Cell Carcinoma: Molecular Targets And Clinical Applications, 3rd Edition
    Publisher: Springer; 3rd ed. 2015 edition (November 27, 2014)
    Year: 2015
    ISBN-13: 9781493916221 (978-1-4939-1622-1), 9781493916214 (978-1-4939-1621-4), 9781493950638 (978-1-4939-5063-8)
    ISBN-10: 149391622X, 1493916211, 1493950630
    Pages: 613
    Language: English
    Genre: Medicine: Oncology
    File type: PDF (True)
    Quality: 10/10
    Price: 166.39 €


    The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.

    Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.

    -------------